Coronavirus disease 2019 (COVID-19) disrupts the intestinal micro-ecological balance, and
patients often develop the intestinal disease. The gut is the largest immune organ in the …

Over the last decade, it has become increasingly apparent that the microbiome is a central
component in human well-being and illness. However, to establish innovative therapeutic …

Background Coronavirus disease 2019 (COVID-19) has affected millions of lives globally.
However, the disease has presented more extreme challenges for developing countries that …

COVID-19, which is caused by the novel coronavirus SARS-CoV-2 (Severe Acute
Respiratory Syndrome Coronavirus 2), is the deadliest outbreak of this millennium. Despite …

The COVID-19 pandemic has led to an unprecedented closure of schools in terms of
duration. The option of school closure, SARS-CoV-2 initially being poorly known, was …

Multimodal ultrasound imaging with conventional B-mode, elastography, and parametric
analysis of contrast-enhanced ultrasound (CEUS): A novel approach to assess small bowel …

Purpose The aim of this study was to describe the incidence and risk factors for hospital
readmission and infection during the months after COVID-19 hospital admission. Methods …

After healing from COVID-19, patients often experience a slew of symptoms known as post
COVID-19 sequelae. Despite the fact that the SARS-CoV-2 pandemic is still ongoing, post …

Introduction The gut microbiota (GM) play a significant role in the infectivity and severity of
COVID-19 infection. However, the available literature primarily focuses on adult patients and …

Background and study aim Anti-Saccharomyces cerevisiae antibodies (ASCA) have been
described in many autoimmune diseases (AIDs). Coronavirus disease 2019 (COVID-19) …